Phreesia (PHR) | Financial Analysis & Statements
Phreesia Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2026Income Metrics
Revenue
127.1M
Gross Profit
86.7M
68.21%
Operating Income
-5.6M
-4.37%
Net Income
1.3M
1.02%
EPS (Diluted)
$0.02
Balance Sheet Metrics
Total Assets
663.8M
Total Liabilities
326.6M
Shareholders Equity
337.2M
Debt to Equity
0.97
Cash Flow Metrics
Operating Cash Flow
39.8M
Free Cash Flow
28.5M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2026
Phreesia Income Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 480.6M | 419.8M | 356.3M | 280.9M | 213.2M |
| Cost of Goods Sold | 154.1M | 134.9M | 124.0M | 109.3M | 81.4M |
| Gross Profit | 326.5M | 284.9M | 232.3M | 171.6M | 131.8M |
| Gross Margin % | 67.9% | 67.9% | 65.2% | 61.1% | 61.8% |
| Operating Expenses | |||||
| Research & Development | 121.5M | 117.4M | 112.3M | 91.2M | 52.3M |
| Selling, General & Administrative | 180.1M | 197.7M | 226.9M | 231.6M | 175.1M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 301.6M | 315.1M | 339.3M | 322.9M | 227.4M |
| Operating Income | -6.6M | -58.1M | -136.5M | -176.6M | -116.8M |
| Operating Margin % | -1.4% | -13.8% | -38.3% | -62.9% | -54.8% |
| Non-Operating Items | |||||
| Interest Income | 2.2M | 2.7M | 4.1M | 2.5M | 79.0K |
| Interest Expense | 7.0M | 2.3M | 1.9M | 1.4M | 1.2M |
| Other Non-Operating Income | 2.5M | 2.0M | -1.1M | -175.0K | -78.0K |
| Pre-tax Income | -8.9M | -55.8M | -135.3M | -175.7M | -118.0M |
| Income Tax | -11.2M | 2.7M | 1.5M | 483.0K | 182.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | 2.3M | -58.5M | -136.9M | -176.1M | -118.2M |
| Net Margin % | 0.5% | -13.9% | -38.4% | -62.7% | -55.4% |
| Key Metrics | |||||
| EBITDA | 30.0M | -25.6M | -102.9M | -148.9M | -95.5M |
| EPS (Basic) | $0.04 | $-1.02 | $-2.51 | $-3.36 | $-2.37 |
| EPS (Diluted) | $0.04 | $-1.02 | $-2.51 | $-3.36 | $-2.37 |
| Basic Shares Outstanding | 59737915 | 57589687 | 54561449 | 52440067 | 49888436 |
| Diluted Shares Outstanding | 59737915 | 57589687 | 54561449 | 52440067 | 49888436 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Phreesia Balance Sheet From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 73.8M | 84.2M | 87.5M | 176.7M | 313.8M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 93.3M | 70.3M | 62.9M | 51.5M | 40.7M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 37.3M | 33.7M | 4.4M | 3.3M | 2.2M |
| Total Current Assets | 279.8M | 203.3M | 195.7M | 262.4M | 386.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 18.5M | 17.2M | 18.9M | 18.5M | 26.4M |
| Goodwill | 474.2M | 232.6M | 229.5M | 114.0M | 97.7M |
| Intangible Assets | 134.0M | 80.9M | 77.8M | 46.6M | 30.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 57.5M | 3.3M | 3.9M | 5.1M | 7.1M |
| Total Non-Current Assets | 383.9M | 185.1M | 174.6M | 107.6M | 108.1M |
| Total Assets | 663.8M | 388.4M | 370.3M | 370.1M | 494.5M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 11.5M | 5.6M | 8.5M | 10.8M | 5.1M |
| Short-term Debt | 9.2M | 9.0M | 6.4M | 6.1M | 7.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 33.7M | 29.2M | 28.1M | 22.6M | 19.6M |
| Total Current Liabilities | 183.2M | 114.0M | 110.1M | 79.0M | 68.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 93.2M | 8.8M | 5.5M | 3.1M | 8.7M |
| Deferred Tax Liabilities | 4.5M | 484.0K | 270.0K | 0 | - |
| Other Non-Current Liabilities | 47.0K | 185.0K | - | - | - |
| Total Non-Current Liabilities | 143.3M | 9.6M | 8.8M | 3.2M | 8.8M |
| Total Liabilities | 326.6M | 123.6M | 118.9M | 82.2M | 77.2M |
| Equity | |||||
| Common Stock | 620.0K | 601.0K | 577.0K | 542.0K | 521.0K |
| Retained Earnings | -799.2M | -801.5M | -743.0M | -606.1M | -429.9M |
| Treasury Stock | 45.5M | 45.5M | 45.5M | 33.6M | 14.0M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 337.2M | 264.8M | 251.4M | 287.8M | 417.3M |
| Key Metrics | |||||
| Total Debt | 102.4M | 17.8M | 12.0M | 9.2M | 15.8M |
| Working Capital | 96.6M | 89.3M | 85.6M | 183.4M | 317.9M |
Balance Sheet Composition
Phreesia Cash Flow Statement From 2022 to 2026
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.3M | -58.5M | -136.9M | -176.1M | -118.2M |
| Depreciation & Amortization | 31.5M | 27.9M | 29.5M | 25.3M | 21.3M |
| Stock-Based Compensation | 67.5M | 67.0M | 71.6M | 58.8M | 36.1M |
| Working Capital Changes | 2.0M | -5.2M | -13.6M | -6.8M | -8.4M |
| Operating Cash Flow | 95.4M | 33.6M | -45.5M | -93.1M | -64.5M |
| Investing Activities | |||||
| Capital Expenditures | -11.1M | -8.7M | -5.8M | -4.7M | -18.4M |
| Acquisitions | -153.2M | 0 | -14.6M | 0 | -34.4M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -148.6M | -8.7M | -20.4M | -4.7M | -52.8M |
| Financing Activities | |||||
| Share Repurchases | 0 | 0 | -12.2M | -19.4M | -9.0M |
| Dividends Paid | - | - | - | - | 0 |
| Debt Issuance | 110.0M | - | - | - | 0 |
| Debt Repayment | -26.8M | -7.8M | -6.8M | -5.7M | -4.3M |
| Financing Cash Flow | 69.0M | -15.4M | -21.3M | -25.7M | 228.1M |
| Free Cash Flow | 54.4M | 8.3M | -57.5M | -116.3M | -105.5M |
| Net Change in Cash | 15.9M | 9.5M | -87.1M | -123.6M | 110.7M |
Cash Flow Trend
Phreesia Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
229.25
Forward P/E
5.42
Price to Book
1.65
Price to Sales
1.16
PEG Ratio
-1.94
Profitability Ratios
Profit Margin
0.48%
Operating Margin
1.33%
Return on Equity
0.77%
Return on Assets
0.31%
Financial Health
Current Ratio
1.53
Debt to Equity
30.38
Beta
0.86
Per Share Data
EPS (TTM)
$0.04
Book Value per Share
$5.56
Revenue per Share
$8.05
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| PHR | 568.7M | 229.25 | 1.65 | 0.77% | 0.48% | 30.38 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Omnicell | 1.7B | 918.75 | 1.34 | 0.17% | 0.17% | 16.59 |
| Teladoc Health | 1.0B | - | 0.74 | -13.93% | -7.92% | 75.06 |
| Certara | 969.0M | 105.00 | 0.95 | -0.15% | -0.38% | 28.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.






